Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CASTRO, M.D., P.A. v. SANOFI PASTEUR INC.
Case Number:
2:11-cv-07178
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Carella Byrne
- Cohen Milstein
- Cohn Lifland
- Cozen O'Connor
- Fine Kaplan
- Greenspoon Marder
- McElroy Deutsch
- Proskauer Rose
- Radice Law Firm
- Stone Conroy LLC
- Walsh Pizzi
Companies
Sectors & Industries:
-
October 23, 2017
Doctors' Counsel Nab $27M In Sanofi Vaccine Antitrust Row
A New Jersey federal judge on Friday signed off on a $61.5 million agreement to end allegations Sanofi Pasteur Inc. unlawfully bundled its pediatric vaccines, with $20.5 million going toward doctors' attorneys' fees and $7.2 million covering expense reimbursement.
-
January 27, 2017
$61M Ends Sanofi Vaccine Antitrust Dispute
Sanofi Pasteur Inc. has agreed to pay $61.5 million in a five-year class dispute brought by doctors alleging the drug company violated antitrust laws with contracts for its pediatric vaccines, according to an agreement filed in New Jersey federal court Friday.
-
September 30, 2015
Sanofi Vaccine Customers Get Class Cert. In Antitrust Case
A New Jersey federal judge on Wednesday granted class certification in a suit accusing Sanofi Pasteur Inc. of using its market power to impose bundled-pricing contracts on physician buying groups as a means of stifling competition from its rivals.
-
April 10, 2013
Sanofi Can't Revive Antitrust Counterclaim In Vaccine Case
A New Jersey federal judge overseeing a proposed class action claiming Sanofi Pasteur Inc. pushed anti-competitive contract restrictions onto vaccine customers refused Tuesday to let the drugmaker appeal the dismissal of its antitrust counterclaim, calling Sanofi's arguments "unpersuasive."
-
December 21, 2012
Vaccine Buyers Get Sanofi's Antitrust Claim Scrapped
The New Jersey federal judge overseeing a proposed class action claiming Sanofi Pasteur Inc. pushed anti-competitive contract restrictions onto vaccine customers tossed the drugmaker's antitrust counterclaim on Thursday, saying Sanofi hadn't supported assertions that customers colluded to demand discounts that lowered vaccine prices to noncompetitive levels.
-
August 07, 2012
Vaccine Buyers Allowed To Bring Antitrust Suit Against Sanofi
A New Jersey federal judge on Monday refused to throw out medical practitioners' claims that Sanofi Pasteur Inc. pushed anti-competitive contract restrictions onto vaccine customers, finding the plaintiffs had standing to bring the proposed class action and had properly stated claims for monopolization.
-
February 27, 2012
Buying Groups Shook Down Vaccine Customers, Sanofi Says
Sanofi Pasteur Inc. on Monday lashed out at a class action accusing the vaccine maker of pushing anti-competitive contract restrictions onto its customers, claiming that any antitrust activity can be attributed to the use of physician buying groups that negotiate discounted prices for Sanofi vaccines.
-
December 12, 2011
Vaccine Purchasers Accuse Sanofi Of Stifling Competition
Sanofi Pasteur Inc. was hit on Friday in New Jersey federal court with a putative class action accusing the vaccine powerhouse of imposing anti-competitive contract restrictions on its customers that prevent them from seeking vaccines from Sanofi rivals.